The changing faces of IgG4-related disease: Clinical manifestations and pathogenesis

Autoimmunity Reviews

Volumn 14, Issue 10, 2015, Pages 914-922

  Islam, Arshia Duza ^a,b   Selmi, Carlo ^c,d   Datta Mitra, Ananya ^b   Sonu, Rebecca ^a   Chen, Mingyi ^a   Gershwin, M Eric ^a   Raychaudhuri, Siba P ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^d UNIVERSITY OF MILAN   (Italy)

Author keywords

Autoimmune disease; Diagnostic criteria; Histology; Lymphoproliferative; Pancreatitis; Plasma cells; Sclerosing fibrosis

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIBIOTIC AGENT; ANTINUCLEAR ANTIBODY; ASPARTATE AMINOTRANSFERASE; B CELL ACTIVATING FACTOR; BILIRUBIN; C REACTIVE PROTEIN; CELL NUCLEUS ANTIGEN; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERLEUKIN 4; PREDNISONE; RHEUMATOID FACTOR; STEROID; TRIACYLGLYCEROL LIPASE; IMMUNOGLOBULIN G;

ABNORMAL URINE COMPOSITION; ADAPTIVE IMMUNITY; ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; AMYLOIDOSIS; ANTIBIOTIC THERAPY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; AUTOIMMUNE PANCREATITIS; BASOPHIL; BILIARY STENT; BILIRUBIN BLOOD LEVEL; CASE REPORT; CERVICAL LYMPHADENOPATHY; CHINESE; CLINICAL FEATURE; COMMON BILE DUCT; COMPUTER ASSISTED TOMOGRAPHY; CONNECTIVE TISSUE DISEASE; COUGHING; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; ERYTHROCYTE SEDIMENTATION RATE; EXOPHTHALMOS; EYELID EDEMA; FATIGUE; FECES COLOR; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; FOLLOW UP; GENE OVEREXPRESSION; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOGLOBULIN G4 RELATED DISEASE; IMMUNOPHENOTYPING; INNATE IMMUNITY; MACROPHAGE; MALE; MICROENVIRONMENT; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OBSTRUCTIVE JAUNDICE; PANCREAS TUMOR; PAROTID ENLARGEMENT; PATHOGENESIS; PHENOTYPE; PRACTICE GUIDELINE; PRURITUS; REVIEW; SALIVARY GLAND DISEASE; SARCOIDOSIS; SCLEROSING SIALOADENITIS; SIALOADENITIS; SINUS CONGESTION; TH2 CELL; TRIACYLGLYCEROL LIPASE BLOOD LEVEL; UPPER ABDOMINAL PAIN; VASCULITIS; WEIGHT REDUCTION; XEROPHTHALMIA; XEROSTOMIA; YOUNG ADULT; ANIMAL; AUTOIMMUNE DISEASE; CHRONIC DISEASE; IMMUNOLOGY; RECURRENT DISEASE;

ADAPTIVE IMMUNITY; ANIMALS; AUTOIMMUNE DISEASES; CHRONIC DISEASE; HUMANS; IMMUNITY, INNATE; IMMUNOGLOBULIN G; RECURRENCE;

EID: 84940614717     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2015.06.003     Document Type: Review

References (178)

1. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N Engl J Med 2001, 344:732-738.
2. Mahajan V.S., Mattoo H., Deshpande V., Pillai S.S., Stone J.H. IgG4-related disease. Annu Rev Pathol 2014, 9:315-347.
3. Brito-Zeron P., Ramos-Casals M., Bosch X., Stone J.H. The clinical spectrum of IgG4-related disease. Autoimmun Rev 2014, 13:1203-1210.
4. Perricone G. Hepatic involvement in IgG4-related disease: IgG4-hepatopathy and IgG4-autoimmune hepatitis. Autoimmun Rev 2015, 14:268.
5. Umehara H., Nakajima A., Nakamura T., Kawanami T., Tanaka M., Dong L., et al. IgG4-related disease and its pathogenesis-cross-talk between innate and acquired immunity. Int Immunol 2014, 26:585-595.
6. Cantarini L., Lopalco G., Selmi C., Napodano S., De Rosa G., Caso F., et al. Autoimmunity and autoinflammation as the yin and yang of idiopathic recurrent acute pericarditis. Autoimmun Rev 2015, 14:90-97.
7. Selmi C. Diagnosis and classification of autoimmune uveitis. Autoimmun Rev 2014, 13:591-594.
8. Selmi C., Gershwin M.E. Diagnosis and classification of reactive arthritis. Autoimmun Rev 2014, 13:546-549.
9. Novelli L., Chimenti M.S., Chiricozzi A., Perricone R. The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies. Autoimmun Rev 2014, 13:64-69.
10. Papotto P.H., Marengo E.B., Sardinha L.R., Goldberg A.C., Rizzo L.V. Immunotherapeutic strategies in autoimmune uveitis. Autoimmun Rev 2014, 13:909-916.
11. Berrih-Aknin S. Myasthenia gravis: paradox versus paradigm in autoimmunity. J Autoimmun 2014, 52:1-28.
12. Avidan N., Le Panse R., Berrih-Aknin S., Miller A. Genetic basis of myasthenia gravis - a comprehensive review. J Autoimmun 2014, 52:146-153.
13. Henao-Mejia J., Elinav E., Thaiss C.A., Licona-Limon P., Flavell R.A. Role of the intestinal microbiome in liver disease. J Autoimmun 2013, 46:66-73.
14. Leung P.S., Wang J., Naiyanetr P., Kenny T.P., Lam K.S., Kurth M.J., et al. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA. J Autoimmun 2013, 41:79-86.
15. Zen Y., Nakanuma Y. Pathogenesis of IgG4-related disease. Curr Opin Rheumatol 2011, 23:114-118.
16. Kawano M., Mizushima I., Yamaguchi Y., Imai N., Nakashima H., Nishi S., et al. Immunohistochemical characteristics of IgG4-related tubulointerstitial nephritis: detailed analysis of 20 Japanese cases. Int J Rheum Dis 2012, 2012:609795.
17. Saeki Y., Ishihara K. Infection-immunity liaison: pathogen-driven autoimmune-mimicry (PDAIM). Autoimmun Rev 2014, 13:1064-1069.
18. Rigante D., Mazzoni M.B., Esposito S. The cryptic interplay between systemic lupus erythematosus and infections. Autoimmun Rev 2014, 13:96-102.
19. An J., Nakajima T., Shibata H., Arimura T., Yasunami M., Kimura A. A novel link of HLA locus to the regulation of immunity and infection: NFKBIL1 regulates alternative splicing of human immune-related genes and influenza virus M gene. J Autoimmun 2013, 47:25-33.
20. Terrier B., Chaara W., Dufat L., Geri G., Rosenzwajg M., Musset L., et al. Serum biomarker signature identifies patients with B-cell non-Hodgkin lymphoma associated with cryoglobulinemia vasculitis in chronic HCV infection. Autoimmun Rev 2014, 13:319-326.
21. Corthesy B. Role of secretory IgA in infection and maintenance of homeostasis. Autoimmun Rev 2013, 12:661-665.
22. Aalberse R.C., Schuurman J. IgG4 breaking the rules. Immunology 2002, 105:9-19.
23. van der Zee J.S., van Swieten P., Aalberse R.C. Serologic aspects of IgG4 antibodies. II. IgG4 antibodies form small, nonprecipitating immune complexes due to functional monovalency. J Immunol 1986, 137:3566-3571.
24. van der Zee J.S., van Swieten P., Aalberse R.C. Inhibition of complement activation by IgG4 antibodies. Clin Exp Immunol 1986, 64:415-422.
25. Nanda A., O'Connor M., Anand M., Dreskin S.C., Zhang L., Hines B., et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol 2004, 114:1339-1344.
26. Guma M., Firestein G.S. IgG4-related diseases. Best Pract Res Clin Rheumatol 2012, 26:425-438.
27. Nirula A., Glaser S.M., Kalled S.L., Taylor F.R. What is IgG4? A review of the biology of a unique immunoglobulin subtype. Curr Opin Rheumatol 2011, 23:119-124.
28. Ishida M., Hotta M., Kushima R., Shibayama M., Shimizu T., Okabe H. Multiple IgG4-related sclerosing lesions in the maxillary sinus, parotid gland and nasal septum. Pathol Int 2009, 59:670-675.
29. Okazaki K., Uchida K., Koyabu M., Miyoshi H., Takaoka M. Recent advances in the concept and diagnosis of autoimmune pancreatitis and IgG4-related disease. J Gastroenterol 2011, 46:277-288.
30. Fang Y., Hou J., Cai F., Ding X., Liu H. IgG4-associated tubulointerstitial nephritis: two case reports and a literature review. Intern Med 2012, 51:2385-2391.
31. Ingen-Housz-Oro S., Ortonne N., Elhai M., Allanore Y., Aucouturier P., Chosidow O. IgG4-related skin disease successfully treated by thalidomide: a report of 2 cases with emphasis on pathological aspects. JAMA Dermatol 2013, 149:742-747.
32. Takei H., Nagasawa H., Sakai R., Nishimura K., Kurasawa T., Okuyama A., et al. A case of multiple giant coronary aneurysms and abdominal aortic aneurysm coexisting with IgG4-related disease. Intern Med 2012, 51:963-967.
33. Zen Y., Fujii T., Sato Y., Masuda S., Nakanuma Y. Pathological classification of hepatic inflammatory pseudotumor with respect to IgG4-related disease. Mod Pathol 2007, 20:884-894.
34. Tanaka A., Moriyama M., Nakashima H., Miyake K., Hayashida J.N., Maehara T., et al. Th2 and regulatory immune reactions contribute to IgG4 production and the initiation of Mikulicz disease. Arthritis Rheum 2012, 64:254-263.
35. Miyake K., Moriyama M., Aizawa K., Nagano S., Inoue Y., Sadanaga A., et al. Peripheral CD4+ T cells showing a Th2 phenotype in a patient with Mikulicz's disease associated with lymphadenopathy and pleural effusion. Mod Rheumatol 2008, 18:86-90.
36. Aparisi L., Farre A., Gomez-Cambronero L., Martinez J., De Las Heras G., Corts J., et al. Antibodies to carbonic anhydrase and IgG4 levels in idiopathic chronic pancreatitis: relevance for diagnosis of autoimmune pancreatitis. Gut 2005, 54:703-709.
37. Hussain A., Pankhurst T., Goodall M., Colman R., Jefferis R., Savage C.O., et al. Chimeric IgG4 PR3-ANCA induces selective inflammatory responses from neutrophils through engagement of Fcgamma receptors. Immunology 2009, 128:236-244.
38. Umehara H., Nakajima A., Nakamura T., Kawanami T., Tanaka M., Dong L., et al. IgG4-related disease and its pathogenesis - cross-talk between innate and acquired immunity. Int Immunol 2014, 26(11):585-595.
39. Akitake R., Watanabe T., Zaima C., Uza N., Ida H., Tada S., et al. Possible involvement of T helper type 2 responses to Toll-like receptor ligands in IgG4-related sclerosing disease. Gut 2010, 59:542-545.
40. Siddiquee Z., Zane N.A., Smith R.N., Stone J.R. Dense IgG4 plasma cell infiltrates associated with chronic infectious aortitis: implications for the diagnosis of IgG4-related disease. Cardiovasc Pathol 2012, 21:470-475.
41. Guarneri F., Guarneri C., Benvenga S. Helicobacter pylori and autoimmune pancreatitis: role of carbonic anhydrase via molecular mimicry?. J Cell Mol Med 2005, 9:741-744.
42. Frulloni L., Lunardi C., Simone R., Dolcino M., Scattolini C., Falconi M., et al. Identification of a novel antibody associated with autoimmune pancreatitis. N Engl J Med 2009, 361:2135-2142.
43. Schuurman J., Perdok G.J., Gorter A.D., Aalberse R.C. The inter-heavy chain disulfide bonds of IgG4 are in equilibrium with intra-chain disulfide bonds. Mol Immunol 2001, 38:1-8.
44. van der Neut Kolfschoten M., Schuurman J., Losen M., Bleeker W.K., Martinez-Martinez P., Vermeulen E., et al. Anti-inflammatory activity of human IgG4 antibodies by dynamic Fab arm exchange. Science 2007, 317:1554-1557.
45. Plomp J.J., Huijbers M.G., van der Maarel S.M., Verschuuren J.J. Pathogenic IgG4 subclass autoantibodies in MuSK myasthenia gravis. Ann N Y Acad Sci 2012, 1275:114-122.
46. Klooster R., Plomp J.J., Huijbers M.G., Niks E.H., Straasheijm K.R., Detmers F.J., et al. Muscle-specific kinase myasthenia gravis IgG4 autoantibodies cause severe neuromuscular junction dysfunction in mice. Brain 2012, 135:1081-1101.
47. Gniadecki R. Desmoglein autoimmunity in the pathogenesis of pemphigus. Autoimmunity 2006, 39:541-547.
48. Puga I., Cols M., Barra C.M., He B., Cassis L., Gentile M., et al. B cell-helper neutrophils stimulate the diversification and production of immunoglobulin in the marginal zone of the spleen. Nat Immunol 2012, 13:170-180.
49. Cerutti A., Puga I., Cols M. Innate control of B cell responses. Trends Immunol 2011, 32:202-211.
50. Tsuboi H., Matsuo N., Iizuka M., Tsuzuki S., Kondo Y., Tanaka A., et al. Analysis of IgG4 class switch-related molecules in IgG4-related disease. Arthritis Res Ther 2012, 14:R171.
51. Litinskiy M.B., Nardelli B., Hilbert D.M., He B., Schaffer A., Casali P., et al. DCs induce CD40-independent immunoglobulin class switching through BLyS and APRIL. Nat Immunol 2002, 3:822-829.
52. Pone E.J., Zhang J., Mai T., White C.A., Li G., Sakakura J.K., et al. BCR-signalling synergizes with TLR-signalling for induction of AID and immunoglobulin class-switching through the non-canonical NF-kappaB pathway. Nat Commun 2012, 3:767.
53. Sakuma H., Okumura F., Miyabe S., Sugiura M., Joh T., Shimozato K., et al. Analysis of VH gene rearrangement and somatic hypermutation in Sjogren's syndrome and IgG4-related sclerosing sialadenitis. Scand J Immunol 2010, 72:44-49.
54. Frasca D., Riley R.L., Blomberg B.B. Aging murine B cells have decreased class switch induced by anti-CD40 or BAFF. Exp Gerontol 2007, 42:192-203.
55. Qi Q., Liu Y., Cheng Y., Glanville J., Zhang D., Lee J.Y., et al. Diversity and clonal selection in the human T-cell repertoire. Proc Natl Acad Sci U S A 2014, 111:13139-13144.
56. Moriyama M., Tanaka A., Maehara T., Furukawa S., Nakashima H., Nakamura S. T helper subsets in Sjogren's syndrome and IgG4-related dacryoadenitis and sialoadenitis: a critical review. J Autoimmun 2014, 51:81-88.
57. Zen Y., Fujii T., Harada K., Kawano M., Yamada K., Takahira M., et al. Th2 and regulatory immune reactions are increased in immunoglobin G4-related sclerosing pancreatitis and cholangitis. Hepatology 2007, 45:1538-1546.
58. Nakashima H., Miyake K., Moriyama M., Tanaka A., Watanabe M., Abe Y., et al. An amplification of IL-10 and TGF-beta in patients with IgG4-related tubulointerstitial nephritis. Clin Nephrol 2010, 73:385-391.
59. Muller T., Beutler C., Pico A.H., Otten M., Durr A., Al-Abadi H., et al. Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. Gastroenterology 2013, 144:1116-1128.
60. Wynn T.A., Ramalingam T.R. Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 2012, 18:1028-1040.
61. Jeannin P., Lecoanet S., Delneste Y., Gauchat J.F., Bonnefoy J.Y. IgE versus IgG4 production can be differentially regulated by IL-10. J Immunol 1998, 160:3555-3561.
62. Jeannin P., Delneste Y., Lecoanet-Henchoz S., Gretener D., Bonnefoy J.Y. Interleukin-7 (IL-7) enhances class switching to IgE and IgG4 in the presence of T cells via IL-9 and sCD23. Blood 1998, 91:1355-1361.
63. Maehara T., Moriyama M., Nakashima H., Miyake K., Hayashida J.N., Tanaka A., et al. Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease. Ann Rheum Dis 2012, 71:2011-2019.
64. McInnes I.B., Kavanaugh A., Gottlieb A.B., Puig L., Rahman P., Ritchlin C., et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1year results of the phase 3, multicentre, double-blind, placebo-controlled PSUMMIT 1 trial. Lancet 2013, 382:780-789.
65. Kiyama K., Kawabata D., Hosono Y., Kitagori K., Yukawa N., Yoshifuji H., et al. Serum BAFF and APRIL levels in patients with IgG4-related disease and their clinical significance. Arthritis Res Ther 2012, 14:R86.
66. Bombardieri M., Kam N.W., Brentano F., Choi K., Filer A., Kyburz D., et al. A BAFF/APRIL-dependent TLR3-stimulated pathway enhances the capacity of rheumatoid synovial fibroblasts to induce AID expression and Ig class-switching in B cells. Ann Rheum Dis 2011, 70:1857-1865.
67. Liu Y., Yin H., Zhao M., Lu Q. TLR2 and TLR4 in autoimmune diseases: a comprehensive review. Clin Rev Allergy Immunol 2014, 47:136-147.
68. Savic S., Ouboussad L., Dickie L.J., Geiler J., Wong C., Doody G.M., et al. TLR dependent XBP-1 activation induces an autocrine loop in rheumatoid arthritis synoviocytes. J Autoimmun 2014, 50:59-66.
69. Wang Z., Zheng Y., Hou C., Yang L., Li X., Lin J., et al. DNA methylation impairs TLR9 induced Foxp3 expression by attenuating IRF-7 binding activity in fulminant type 1 diabetes. J Autoimmun 2013, 41:50-59.
70. Miyoshi H., Uchida K., Taniguchi T., Yazumi S., Matsushita M., Takaoka M., et al. Circulating naive and CD4+CD25 high regulatory T cells in patients with autoimmune pancreatitis. Pancreas 2008, 36:133-140.
71. He B., Qiao X., Cerutti A. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10. J Immunol 2004, 173:4479-4491.
72. Watanabe T., Yamashita K., Fujikawa S., Sakurai T., Kudo M., Shiokawa M., et al. Involvement of activation of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors in enhanced IgG4 responses in autoimmune pancreatitis. Arthritis Rheum 2012, 64:914-924.
73. Kamisawa T., Egawa N., Nakajima H. Autoimmune pancreatitis is a systemic autoimmune disease. Am J Gastroenterol 2003, 98:2811-2812.
74. Kamisawa T., Funata N., Hayashi Y., Eishi Y., Koike M., Tsuruta K., et al. A new clinicopathological entity of IgG4-related autoimmune disease. J Gastroenterol 2003, 38:982-984.
75. Fong W.W., Thumboo J., Azhar R., Yoong J.K. IgG4-related disease in Singapore: a description of two cases and review of the literature. Int J Rheum Dis 2013, 16:93-97.
76. Deshpande V. The pathology of IgG4-related disease: critical issues and challenges. Semin Diagn Pathol 2012, 29:191-196.
77. Okazaki K., Uchida K., Miyoshi H., Ikeura T., Takaoka M., Nishio A. Recent concepts of autoimmune pancreatitis and IgG4-related disease. Clin Rev Allergy Immunol 2011, 41:126-138.
78. Sah R.P., Chari S.T. Serologic issues in IgG4-related systemic disease and autoimmune pancreatitis. Curr Opin Rheumatol 2011, 23:108-113.
79. Divatia M., Kim S.A., Ro J.Y. IgG4-related sclerosing disease, an emerging entity: a review of a multi-system disease. Yonsei Med J 2012, 53:15-34.
80. Kamisawa T., Okamoto A. IgG4-related sclerosing disease. World J Gastroenterol 2008, 14:3948-3955.
81. Takuma K., Kamisawa T., Igarashi Y. Autoimmune pancreatitis and IgG4-related sclerosing cholangitis. Curr Opin Rheumatol 2011, 23:80-87.
82. Kamisawa T., Takuma K., Hara S., Tabata T., Kuruma S., Inaba Y., et al. Management strategies for autoimmune pancreatitis. Expert Opin Pharmacother 2011, 12:2149-2159.
83. Shimatsu A., Oki Y., Fujisawa I., Sano T. Pituitary and stalk lesions (infundibulo-hypophysitis) associated with immunoglobulin G4-related systemic disease: an emerging clinical entity. Endocr J 2009, 56:1033-1041.
84. Sakamaki A., Kamimura K., Shioji K., Sakurada J., Nakatsue T., Wada Y., et al. Immunoglobulin G4-related disease with several inflammatory foci. Intern Med 2013, 52:457-462.
85. Koizumi S., Kamisawa T., Kuruma S., Tabata T., Chiba K., Iwasaki S., et al. Immunoglobulin G4-related gastrointestinal diseases, are they immunoglobulin G4-related diseases. World J Gastroenterol 2013, 19:5769-5774.
86. Lopes J., Hochwald S.N., Lancia N., Dixon L.R., Ben-David K. Autoimmune esophagitis: IgG4-related tumors of the esophagus. J Gastrointest Surg 2010, 14:1031-1034.
87. Narula N., Vasudev M., Marshall J.K. IgG(4)-related sclerosing disease: a novel mimic of inflammatory bowel disease. Dig Dis Sci 2010, 55:3047-3051.
88. Takuma K., Kamisawa T., Gopalakrishna R., Hara S., Tabata T., Inaba Y., et al. Strategy to differentiate autoimmune pancreatitis from pancreas cancer. World J Gastroenterol 2012, 18:1015-1020.
89. Nakazawa T., Ando T., Hayashi K., Naitoh I., Ohara H., Joh T. Diagnostic procedures for IgG4-related sclerosing cholangitis. J Hepatobiliary Pancreat Sci 2011, 18:127-136.
90. Bateman A.C., Deheragoda M.G. IgG4-related systemic sclerosing disease - an emerging and under-diagnosed condition. Histopathology 2009, 55:373-383.
91. Montano-Loza A.J., Lalor E., Mason A.L. Recognizing immunoglobulin G4 related overlap syndromes in patients with pancreatic and hepatobiliary diseases. Can J Gastroenterol 2008, 22:840-846.
92. Kamisawa T., Okamoto A. Autoimmune pancreatitis: proposal of IgG4-related sclerosing disease. J Gastroenterol 2006, 41:613-625.
93. Detlefsen S., Drewes A.M. Autoimmune pancreatitis. Scand J Gastroenterol 2009, 44:1391-1407.
94. Shinagare S., Shinagare A.B., Deshpande V. Autoimmune pancreatitis: a guide for the histopathologist. Semin Diagn Pathol 2012, 29:197-204.
95. Kamisawa T., Takuma K., Egawa N., Tsuruta K., Sasaki T. Autoimmune pancreatitis and IgG4-related sclerosing disease. Nat Rev Gastroenterol Hepatol 2010, 7:401-409.
96. Zhang L., Smyrk T.C. Autoimmune pancreatitis and IgG4-related systemic diseases. Int J Clin Exp Pathol 2010, 3:491-504.
97. Psarras K., Baltatzis M.E., Pavlidis E.T., Lalountas M.A., Pavlidis T.E., Sakantamis A.K. Autoimmune pancreatitis versus pancreatic cancer: a comprehensive review with emphasis on differential diagnosis. Hepatobiliary Pancreat Dis Int 2011, 10:465-473.
98. Li J., Zhao C., Shen Y. Autoimmune cholangitis and cholangiocarcinoma. J Gastroenterol Hepatol 2012, 27:1783-1789.
99. Novotny I., Dite P., Trna J., Lata J., Husova L., Geryk E. Immunoglobulin G4-related cholangitis: a variant of IgG4-related systemic disease. Dig Dis 2012, 30:216-219.
100. Alderlieste Y.A., van den Elzen B.D., Rauws E.A., Beuers U. Immunoglobulin G4-associated cholangitis: one variant of immunoglobulin G4-related systemic disease. Digestion 2009, 79:220-228.
101. Yao Q., Wu G., Hoschar A. IgG4-related Mikulicz's disease is a multiorgan lymphoproliferative disease distinct from Sjogren's syndrome: a Caucasian patient and literature review. Clin Exp Rheumatol 2013, 31:289-294.
102. Tasaki T., Matsuyama A., Tabata T., Suzuki H., Yamada S., Sasaguri Y., et al. Sclerosing mucoepidermoid carcinoma with eosinophilia of the salivary gland: case report and review of the literature. Pathol Int 2013, 63:125-131.
103. Ferry J.A., Deshpande V. IgG4-related disease in the head and neck. Semin Diagn Pathol 2012, 29:235-244.
104. Masaki Y., Sugai S., Umehara H. IgG4-related diseases including Mikulicz's disease and sclerosing pancreatitis: diagnostic insights. J Rheumatol 2010, 37:1380-1385.
105. Abe T., Sato T., Tomaru Y., Sakata Y., Kokabu S., Hori N., et al. Immunoglobulin G4-related sclerosing sialadenitis: report of two cases and review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2009, 108:544-550.
106. Yamamoto M., Takahashi H., Ohara M., Suzuki C., Naishiro Y., Yamamoto H., et al. A new conceptualization for Mikulicz's disease as an IgG4-related plasmacytic disease. Mod Rheumatol 2006, 16:335-340.
107. Himi T., Takano K., Yamamoto M., Naishiro Y., Takahashi H. A novel concept of Mikulicz's disease as IgG4-related disease. Auris Nasus Larynx 2012, 39:9-17.
108. Geyer J.T., Deshpande V. IgG4-associated sialadenitis. Curr Opin Rheumatol 2011, 23:95-101.
109. Barrera M.J., Bahamondes V., Sepulveda D., Quest A.F., Castro I., Cortes J., et al. Sjogren's syndrome and the epithelial target: a comprehensive review. J Autoimmun 2013, 42:7-18.
110. Kyriakidis N.C., Kapsogeorgou E.K., Tzioufas A.G. A comprehensive review of autoantibodies in primary Sjogren's syndrome: clinical phenotypes and regulatory mechanisms. J Autoimmun 2014, 51:67-74.
111. Yamamoto M., Takahashi H., Naishiro Y., Isshiki H., Ohara M., Suzuki C., et al. Mikulicz's disease and systemic IgG4-related plasmacytic syndrome (SIPS). Nihon Rinsho Meneki Gakkai Kaishi 2008, 31:1-8.
112. Khan T.T., Halat S.K., Al Hariri A.B. Lacrimal gland sparing IgG4-related disease in the orbit. Ocul Immunol Inflamm 2013, 21:220-224.
113. Fraser C.L., Skalicky S.E., Gurbaxani A., McCluskey P. Ocular myositis. Curr Allergy Asthma Rep 2013, 13:315-321.
114. Berry-Brincat A., Rose G.E. Idiopathic orbital inflammation: a new dimension with the discovery of immunoglobulin G4-related disease. Curr Opin Ophthalmol 2012, 23:415-419.
115. Lindfield D., Attfield K., McElvanney A. Systemic immunoglobulin G4 (IgG4) disease and idiopathic orbital inflammation; removing 'idiopathic' from the nomenclature?. Eye (Lond) 2012, 26:623-629.
116. Wallace Z.S., Khosroshahi A., Jakobiec F.A., Deshpande V., Hatton M.P., Ritter J., et al. IgG4-related systemic disease as a cause of "idiopathic" orbital inflammation, including orbital myositis, and trigeminal nerve involvement. Surv Ophthalmol 2012, 57:26-33.
117. da Fonseca F.L., Ramos Rde I., de Lima P.P., Nogueira A.B., Matayoshi S. Unilateral eyelid mass as an unusual presentation of ocular adnexal IgG4-related inflammation. Cornea 2013, 32:517-519.
118. Shin Y.U., Oh Y.H., Lee Y.J. Unusual involvement of IgG4-related sclerosing disease in lacrimal and submandibular glands and extraocular muscles. Korean J Ophthalmol 2012, 26:216-221.
119. Schiffenbauer A.I., Wahl C., Pittaluga S., Jaffe E.S., Hoffman R., Khosroshahi A., et al. IgG4-related disease presenting as recurrent mastoiditis. Laryngoscope 2012, 122:681-684.
120. O'Malley D.P., Grimm K.E. Reactive lymphadenopathies that mimic lymphoma: entities of unknown etiology. Semin Diagn Pathol 2013, 30:137-145.
121. Cheuk W., Chan J.K. Lymphadenopathy of IgG4-related disease: an underdiagnosed and overdiagnosed entity. Semin Diagn Pathol 2012, 29:226-234.
122. Shimizu I., Nasu K., Sato K., Ueki H., Akahane D., Sumi M., et al. Lymphadenopathy of IgG4-related sclerosing disease: three case reports and review of literature. Int J Hematol 2010, 92:751-756.
123. Ishizaka N., Sakamoto A., Imai Y., Terasaki F., Nagai R. Multifocal fibrosclerosis and IgG4-related disease involving the cardiovascular system. J Cardiol 2012, 59:132-138.
124. Zen Y., Kasashima S., Inoue D. Retroperitoneal and aortic manifestations of immunoglobulin G4-related disease. Semin Diagn Pathol 2012, 29:212-218.
125. Ishizaka N. IgG4-related disease underlying the pathogenesis of coronary artery disease. Clin Chim Acta 2013, 415:220-225.
126. Stone J.R. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011, 23:88-94.
127. Kasashima S., Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr Opin Rheumatol 2011, 23:18-23.
128. Kim H.H., Hur Y.H., Koh Y.S., Kim J.C., Kim H.J., Kim J.W., et al. Sclerosing angiomatoid nodular transformation of the spleen related to IgG4-associated disease: report of a case. Surg Today 2013, 43:930-936.
129. Miyashita T., Yoshioka K., Nakamura T., Kubo Y., Inoue T., Morikawa T., et al. A case of lymphomatoid granulomatosis-like lung lesions with abundant infiltrating IgG4-positive plasma cells whose serum IgG4 levels became high following the start of corticosteroid therapy. Intern Med 2010, 49:2007-2011.
130. Yi E.S., Sekiguchi H., Peikert T., Ryu J.H., Colby T.V. Pathologic manifestations of immunoglobulin(Ig)G4-related lung disease. Semin Diagn Pathol 2012, 29:219-225.
131. Shigemitsu H., Koss M.N. IgG4-related interstitial lung disease: a new and evolving concept. Curr Opin Pulm Med 2009, 15:513-516.
132. Yamashita H., Takahashi Y., Ishiura H., Kano T., Kaneko H., Mimori A. Hypertrophic pachymeningitis and tracheobronchial stenosis in IgG4-related disease: case presentation and literature review. Intern Med 2012, 51:935-941.
133. Dias O.M., Kawassaki Ade M., Haga H., Cukier A., Carvalho C.R. Immunoglobulin G4-related systemic sclerosing disease in a patient with sclerosing cholangitis, inflammatory pseudotumors of the lung and multiple radiological patterns: a case report. Clinics (Sao Paulo) 2011, 66:1983-1986.
134. Kitada M., Matuda Y., Hayashi S., Ishibashi K., Oikawa K., Miyokawa N., et al. IgG4-related lung disease showing high standardized uptake values on FDG-PET: report of two cases. J Cardiothorac Surg 2013, 8:160.
135. Marando A., D'Ambrosio G., Catanzaro F., La Rosa S., Sessa F. IgG4-related disease of the ureter: report of two cases and review of the literature. Virchows Arch 2013, 462:673-678.
136. Tsubata Y., Akiyama F., Oya T., Ajiro J., Saeki T., Nishi S., et al. IgG4-related chronic tubulointerstitial nephritis without autoimmune pancreatitis and the time course of renal function. Intern Med 2010, 49:1593-1598.
137. Nishi S., Imai N., Yoshida K., Ito Y., Saeki T. Clinicopathological findings of immunoglobulin G4-related kidney disease. Clin Exp Nephrol 2011, 15:810-819.
138. Cornell L.D. IgG4-related kidney disease. Curr Opin Nephrol Hypertens 2012, 21:279-288.
139. Kakudo K., Li Y., Hirokawa M., Ozaki T. Diagnosis of Hashimoto's thyroiditis and IgG4-related sclerosing disease. Pathol Int 2011, 61:175-183.
140. Bando H., Iguchi G., Fukuoka H., Taniguchi M., Yamamoto M., Matsumoto R., et al. The prevalence of IgG4-related hypophysitis in 170 consecutive patients with hypopituitarism and/or central diabetes insipidus and review of the literature. Eur J Endocrinol 2014, 170:161-172.
141. Patel S.M., Szostek J.H. IgG4-related systemic disease in a Native American man. Intern Med 2011, 50:931-934.
142. Hori M., Makita N., Andoh T., Takiyama H., Yajima Y., Sakatani T., et al. Long-term clinical course of IgG4-related systemic disease accompanied by hypophysitis. Endocr J 2010, 57:485-492.
143. Hattori Y., Tahara S., Ishii Y., Kitamura T., Inomoto C., Osamura R.Y., et al. A case of IgG4-related hypophysitis without pituitary insufficiency. J Clin Endocrinol Metab 2013, 98:1808-1811.
144. Hamaguchi Y., Fujimoto M., Matsushita Y., Kitamura-Sawada S., Kawano M., Takehara K. IgG4-related skin disease, a mimic of angiolymphoid hyperplasia with eosinophilia. Dermatology 2011, 223:301-305.
145. Kakuchi Y., Yamada K., Suzuki Y., Ito N., Yagi K., Matsumura M., et al. IgG4-related skin lesions in a patient with IgG4-related chronic sclerosing dacryoadenitis and sialoadenitis. Intern Med 2011, 50:1465-1469.
146. Lindstrom K.M., Cousar J.B., Lopes M.B. IgG4-related meningeal disease: clinico-pathological features and proposal for diagnostic criteria. Acta Neuropathol 2010, 120:765-776.
147. Masterson L., Del Pero M.M., Donnelly N., Moffat D.A., Rytina E. Immunoglobulin G4 related systemic sclerosing disease involving the temporal bone. J Laryngol Otol 2010, 124:1106-1110.
148. Kanda G., Ryu T., Shirai T., Ijichi M., Hishima T., Kitamura S., et al. Peripheral T-cell lymphoma that developed during the follow-up of IgG4-related disease. Intern Med 2011, 50:155-160.
149. Sato Y., Notohara K., Kojima M., Takata K., Masaki Y., Yoshino T. IgG4-related disease: historical overview and pathology of hematological disorders. Pathol Int 2010, 60:247-258.
150. Ito M., Naruke Y., Mihara Y., So K., Miyashita T., Origuchi T., et al. Thyroid papillary carcinoma with solid sclerosing change in IgG4-related sclerosing disease. Pathol Int 2011, 61:589-592.
151. Sanchez-Castanon M., las Heras-Castano G., Lopez-Hoyos M. Autoimmune pancreatitis: an underdiagnosed autoimmune disease with clinical, imaging and serological features. Autoimmun Rev 2010, 9:237-240.
152. Masaki Y., Kurose N., Umehara H. IgG4-related disease: a novel lymphoproliferative disorder discovered and established in Japan in the 21st century. J Clin Exp Hematop 2011, 51:13-20.
153. Deshpande V., Zen Y., Chan J.K., Yi E.E., Sato Y., Yoshino T., et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012, 25:1181-1192.
154. Detlefsen S. IgG4-related disease: a systemic condition with characteristic microscopic features. Histol Histopathol 2013, 28:565-584.
155. Hirabayashi K., Zamboni G. IgG4-related disease. Pathologica 2012, 104:43-55.
156. Cheuk W., Chan J.K. IgG4-related sclerosing disease: a critical appraisal of an evolving clinicopathologic entity. Adv Anat Pathol 2010, 17:303-332.
157. Wimmer D.B., Ro J.Y., Lewis A., Schwartz M.R., Caplan R., Schwarz P., et al. Extranodal Rosai-Dorfman disease associated with increased numbers of immunoglobulin g4 plasma cells involving the colon: case report with literature review. Arch Pathol Lab Med 2013, 137:999-1004.
158. Takahashi H., Yamamoto M., Suzuki C., Naishiro Y., Shinomura Y., Imai K. The birthday of a new syndrome: IgG4-related diseases constitute a clinical entity. Autoimmun Rev 2010, 9:591-594.
159. Umehara H., Okazaki K., Masaki Y., Kawano M., Yamamoto M., Saeki T., et al. Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011. Mod Rheumatol 2012, 22:21-30.
160. Kivity S., Arango M.T., Ehrenfeld M., Tehori O., Shoenfeld Y., Anaya J.M., et al. Infection and autoimmunity in Sjogren's syndrome: a clinical study and comprehensive review. J Autoimmun 2014, 51:17-22.
161. Seror R., Theander E., Bootsma H., Bowman S.J., Tzioufas A., Gottenberg J.E., et al. Outcome measures for primary Sjogren's syndrome: a comprehensive review. J Autoimmun 2014, 51:51-56.
162. Pezzilli R., Cariani G., Santini D., Calculli L., Casadei R., Morselli-Labate A.M., et al. Therapeutic management and clinical outcome of autoimmune pancreatitis. Scand J Gastroenterol 2011, 46:1029-1038.
163. Kamisawa T., Okazaki K., Kawa S., Ito T., Inui K., Irie H., et al. Amendment of the Japanese Consensus Guidelines for Autoimmune Pancreatitis, 2013 III. Treatment and prognosis of autoimmune pancreatitis. J Gastroenterol 2014, 49:961-970.
164. Ghazale A., Chari S.T., Zhang L., Smyrk T.C., Takahashi N., Levy M.J., et al. Immunoglobulin G4-associated cholangitis: clinical profile and response to therapy. Gastroenterology 2008, 134:706-715.
165. Berman H., Rodriguez-Pinto I., Cervera R., Morel N., Costedoat-Chalumeau N., Erkan D., et al. Rituximab use in the catastrophic antiphospholipid syndrome: descriptive analysis of the CAPS registry patients receiving rituximab. Autoimmun Rev 2013, 12:1085-1090.
166. Kattah A.G., Fervenza F.C., Roccatello D. Rituximab-based novel strategies for the treatment of immune-mediated glomerular diseases. Autoimmun Rev 2013, 12:854-859.
167. Shetty S., Ahmed A.R. Preliminary analysis of mortality associated with rituximab use in autoimmune diseases. Autoimmunity 2013, 46:487-496.
168. Cambridge G., Perry H.C., Nogueira L., Serre G., Parsons H.M., De La Torre I., et al. The effect of B-cell depletion therapy on serological evidence of B-cell and plasmablast activation in patients with rheumatoid arthritis over multiple cycles of rituximab treatment. J Autoimmun 2014, 50:67-76.
169. Kawa S., Hamano H. Clinical features of autoimmune pancreatitis. J Gastroenterol 2007, 42(Suppl. 18):9-14.
170. Bernal-Bello D., Garcia de Tena J., Simeon-Aznar C., Fonollosa-Pla V. Systemic sclerosis, breast cancer and calcium channel blockers: a new player on the scene?. Autoimmun Rev 2014, 13:880-881.
171. Colaci M., Giuggioli D., Vacchi C., Lumetti F., Iachetta F., Marcheselli L., et al. Breast cancer in systemic sclerosis: results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. Autoimmun Rev 2014, 13:132-137.
172. Yang C.Y., Ma X., Tsuneyama K., Huang S., Takahashi T., Chalasani N.P., et al. IL-12/Th1 and IL-23/Th17 biliary microenvironment in primary biliary cirrhosis: implications for therapy. Hepatology 2014, 59:1944-1953.
173. Zhang J., Zhang W., Leung P.S., Bowlus C.L., Dhaliwal S., Coppel R.L., et al. Ongoing activation of autoantigen-specific B cells in primary biliary cirrhosis. Hepatology 2014, 60:1708-1716.
174. Wang L., Sun Y., Zhang Z., Jia Y., Zou Z., Ding J., et al. CXCR5+ CD4+ T follicular helper cells participate in the pathogenesis of primary biliary cirrhosis. Hepatology 2015, 61:627-638.
175. Yao Y., Yang W., Yang Y.Q., Ma H.D., Lu F.T., Li L., et al. Distinct from its canonical effects, deletion of IL-12p40 induces cholangitis and fibrosis in interleukin-2Ralpha(-/-) mice. J Autoimmun 2014, 51:99-108.
176. Huang W., Kachapati K., Adams D., Wu Y., Leung P.S., Yang G.X., et al. Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells. J Autoimmun 2014, 50:123-134.
177. Tanaka H., Yang G.X., Iwakoshi N., Knechtle S.J., Kawata K., Tsuneyama K., et al. Anti-CD40 ligand monoclonal antibody delays the progression of murine autoimmune cholangitis. Clin Exp Immunol 2013, 174:364-371.
178. Lleo A., Zhang W., McDonald W.H., Seeley E.H., Leung P.S., Coppel R.L., et al. Shotgun proteomics: identification of unique protein profiles of apoptotic bodies from biliary epithelial cells. Hepatology 2014, 60:1314-1323.